183 related articles for article (PubMed ID: 30062624)
1. Clinical Implications of Serum Biomarkers of Cardiac Stress in Aortic Stenosis.
Patel N; Kumbhani DJ
Curr Heart Fail Rep; 2018 Oct; 15(5):281-286. PubMed ID: 30062624
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
[TBL] [Abstract][Full Text] [Related]
3. Effect of the 2017 European Guidelines on Reclassification of Severe Aortic Stenosis and Its Influence on Management Decisions for Initially Asymptomatic Aortic Stenosis.
Chan DCS; Singh A; Greenwood JP; Dawson DK; Lang CC; Berry C; Pakkal M; Everett RJ; Dweck MR; Ng LL; McCann GP
Circ Cardiovasc Imaging; 2020 Dec; 13(12):e011763. PubMed ID: 33287584
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study.
Cimadevilla C; Cueff C; Hekimian G; Dehoux M; Lepage L; Iung B; Duval X; Huart V; Tubach F; Vahanian A; Messika-Zeitoun D
Heart; 2013 Apr; 99(7):461-7. PubMed ID: 23349346
[TBL] [Abstract][Full Text] [Related]
5. NT-proBNP for risk stratification of nonagenarian patients with severe symptomatic aortic stenosis.
Raposeiras-Roubín S; Abu-Assi E; López-Rodríguez E; Agra-Bermejo R; Pereira-López EM; Calvo-Iglesias F; Íñiguez-Romo A
Int J Cardiol; 2016 Nov; 223():785-786. PubMed ID: 27573609
[No Abstract] [Full Text] [Related]
6. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.
Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H
Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847
[TBL] [Abstract][Full Text] [Related]
7. Blood, tissue and imaging biomarkers in calcific aortic valve stenosis: past, present and future.
Shen M; Tastet L; Bergler-Klein J; Pibarot P; Clavel MA
Curr Opin Cardiol; 2018 Mar; 33(2):125-133. PubMed ID: 29194051
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Schmid H; Trenkwalder T; Mayr NP; Joner M; Kasel AM; Holdenrieder S; Nunez J; Sanchis J; Bodi V; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Am J Cardiol; 2018 Feb; 121(4):461-468. PubMed ID: 29306485
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis.
Goodman A; Kusunose K; Popovic ZB; Parikh R; Barr T; Sabik JF; Rodriguez LL; Svensson LG; Griffin BP; Desai MY
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26732551
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
[TBL] [Abstract][Full Text] [Related]
11. Nt-ProBNP Discriminatory Role Between Symptomatic and Asymptomatic Patients with Severe Valvular Aortic Stenosis.
Antova E; Petkovska L; Bosevski M; Stojkovik J; Hadzy-Petrushev N; Kamkin A; Mladenov M
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2018 Jul; 39(1):15-28. PubMed ID: 30110268
[No Abstract] [Full Text] [Related]
12. Natriuretic peptides for risk stratification of patients with valvular aortic stenosis.
Parikh V; Kim C; Siegel RJ; Arsanjani R; Rader F
Circ Heart Fail; 2015 Mar; 8(2):373-80. PubMed ID: 25783947
[No Abstract] [Full Text] [Related]
13. Two-dimensional strain for the assessment of left ventricular function in low flow-low gradient aortic stenosis, relationship to hemodynamics, and outcome: a substudy of the multicenter TOPAS study.
Bartko PE; Heinze G; Graf S; Clavel MA; Khorsand A; Bergler-Klein J; Burwash IG; Dumesnil JG; Sénéchal M; Baumgartner H; Rosenhek R; Pibarot P; Mundigler G
Circ Cardiovasc Imaging; 2013 Mar; 6(2):268-76. PubMed ID: 23275349
[TBL] [Abstract][Full Text] [Related]
14. Timing of Dynamic NT-proBNP and hs-cTnT Response to Exercise Challenge in Asymptomatic Children with Moderate Aortic Valve Regurgitation or Moderate Aortic Valve Stenosis.
Mawad W; Abadir S; Fournier A; Bigras JL; Curnier D; Kadem L; Dahdah N
Pediatr Cardiol; 2015 Dec; 36(8):1735-41. PubMed ID: 26123813
[TBL] [Abstract][Full Text] [Related]
15. Determinants and prognostic value of B-type natriuretic peptide in patients with aortic valve stenosis.
Nguyen V; Cimadevilla C; Arangalage D; Dehoux M; Codogno I; Duval X; Tubiana S; Vahanian A; Messika-Zeitoun D
Int J Cardiol; 2017 Mar; 230():371-377. PubMed ID: 28062138
[TBL] [Abstract][Full Text] [Related]
16. Heartbeat: Risk stratification for asymptomatic severe aortic stenosis.
Otto CM
Heart; 2019 Mar; 105(5):347-349. PubMed ID: 31693480
[No Abstract] [Full Text] [Related]
17. Advanced symptoms are associated with myocardial damage in patients with severe aortic stenosis.
Spampinato RA; Tasca M; Borger MA; Schloma V; Dmitrieva Y; Mende M; Noack T; Strotdrees E; Mohr FW
J Cardiol; 2017 Jul; 70(1):41-47. PubMed ID: 27876412
[TBL] [Abstract][Full Text] [Related]
18. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of paravalvular leaks on biomarkers and survival after transcatheter aortic valve implantation.
Schewel D; Frerker C; Schewel J; Wohlmuth P; Meincke F; Thielsen T; Kreidel F; Kuck KH; Schäfer U
Catheter Cardiovasc Interv; 2015 Feb; 85(3):502-14. PubMed ID: 24259366
[TBL] [Abstract][Full Text] [Related]
20. Low-flow severe aortic stenosis with preserved ejection fraction, N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiovascular remodeling.
Mizia-Stec K; Adamczyk T; Mizia M; Haberka M; Gasior Z; Trusz-Gluza M; Tendera M
J Heart Valve Dis; 2011 May; 20(3):301-10. PubMed ID: 21714421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
